Skip to content

Drug interactions

Dexamethasone-neomycin-polymyxin + Duvelisib

Severity: Minor

Dexamethasone-neomycin-polymyxin and Duvelisib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Duvelisib inhibits CYP3A4 and may raise exposure to CYP3A4 substrates such as dexamethasone. With topical or ophthalmic dexamethasone, the systemic increase is expected to be small.

What this interaction means in plain words

Dexamethasone-neomycin-polymyxin and Duvelisib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dexamethasone-neomycin-polymyxin belongs to Anti Bacterial; Duvelisib belongs to Oncology.

Evidence level: Low

Why it happens

Duvelisib inhibits CYP3A4, reducing dexamethasone clearance.

What to do

No adjustment is usually needed for topical use; monitor for corticosteroid adverse effects if used for a prolonged period over large areas or systemically.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dexamethasone-neomycin-polymyxin and Duvelisib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dexamethasone-neomycin-polymyxin with Duvelisib?

MediHelp rates the interaction as minor. Dexamethasone-neomycin-polymyxin and Duvelisib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Duvelisib inhibits CYP3A4 and may raise exposure to CYP3A4 substrates such as dexamethasone. With topical or ophthalmic dexamethasone, the systemic increase is expected to be small.

How serious is the interaction between Dexamethasone-neomycin-polymyxin and Duvelisib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No adjustment is usually needed for topical use; monitor for corticosteroid adverse effects if used for a prolonged period over large areas or systemically.

What other medicines interact with Dexamethasone-neomycin-polymyxin?

MediHelp also lists interactions of Dexamethasone-neomycin-polymyxin with, for example, Ketorolac, Lapatinib, Levofloxacin. The full list is on the Dexamethasone-neomycin-polymyxin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in